In patients treated with antivitamin K with moderate thrombocytopenia, minor bleeding occurred three times more frequently than in normal patients (IRR 3.03, 95% CI 1.57–5.60), while major bleeding showed a trend toward increased risk (IRR 1.48, 95% CI 0.44–3.98).
← all excerpts
Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia.
1
—
—